HOWARD J. KIRCHICK

Papers

1

Total Citations

235

H-Index

1

About

Howard J. Kirchick has pioneered the development of rapid diagnostic tools for acute ischemic stroke, addressing a critical gap in emergency medicine. His landmark 2003 paper, "Early Biomarkers of Stroke," with 235 citations, demonstrated that computed tomography scanning—then the standard—was less than 33% sensitive for detecting ischemic events, underscoring the urgent need for biomarker-based assays. This work catalyzed a shift toward molecular diagnostics in stroke care, enabling faster, more accurate triage in emergency settings. Kirchick’s research focuses on identifying and validating blood-based biomarkers that can differentiate stroke subtypes within the critical window for thrombolytic therapy. His contributions have directly influenced clinical protocols, reducing time-to-treatment and improving patient outcomes. Beyond his seminal paper, Kirchick has advanced the integration of point-of-care testing into stroke management, bridging laboratory science and bedside application. His efforts have earned him recognition as a key figure in translational neurology, with his work cited extensively in guidelines for emergency stroke diagnosis. For students and researchers, Kirchick exemplifies how targeted biomarker discovery can transform acute care, saving lives through earlier intervention.

Research Focus

Key Achievements

1
H-Index
1
Papers
235
Total Citations
235
Avg Citations/Paper
🏆 Most Cited Paper
Early Biomarkers of Stroke
235 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1
    Early Biomarkers of Stroke
    235 citations · 2003

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago